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Abstract
The purpose of this article is to review calcified or ossified benign soft tissue lesions that may simulate malignancy.We review the
clinical presentations, locations, imaging characteristics, and differential diagnostic considerations of myositis ossificans,
tophaceous gout, benign vascular lesions, calcific tendinopathy with osseous involvement, periosteal chondroma, primary
synovial chondromatosis, Hoffa’s disease, tumoral calcinosis, lipoma with metaplasia, calcifying aponeurotic fibroma, calcific
myonecrosis, ancient schwannoma, and Castleman disease.
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Introduction
Many patients are referred to the radiology department for
evaluation of a soft tissue lesion in daily practice. The vast
majority of soft tissue lesions are benign, with a very good
outcome after resection [1]. Malignant soft tissue lesions are
rare, but they are potentially life-threatening and may pose a
diagnostic and therapeutic challenge [1]. It is the task of the
radiologist to differentiate lesions that are certainly benign
from those that are not, and to provide a differential diagnosis
for lesions that appear malignant or are of unclear nature in
terms of benignancy or malignancy on imaging [2]. The iden-
tification of calcifications or ossification in a soft tissue lesion
is important because it can narrow the differential diagnosis or
be suggestive of a certain diagnosis when combined with oth-
er imaging findings. In addition, differentiating between cal-
cification and ossification can narrow the differential
diagnosis as some pathologies tend to produce ossifications
while other pathologies tend to produce calcifications. The
purpose of this article is to review calcified or ossified benign
soft tissue lesions that may simulate malignancy. We first dis-
cuss how soft tissue calcifications can be differentiated from
ossification on imaging. Subsequently, we review the clinical
presentations, locations, imaging characteristics, and differen-
tial diagnostic considerations of several benign entities with
calcifications or ossifications that may simulate malignancy.
Calcifications versus ossification
Differentiation between calcifications and ossification is very
important in making the correct (differential) diagnosis.
Radiography is usually the initial imaging modality by which
soft tissue calcifications and ossification are detected.
Calcifications normally appear as mineralized densities,
whereas mature bone shows an outer cortex and inner trabec-
ular pattern (Fig. 1) [3]. CT is more sensitive in detecting
calcifications and ossification. Hounsfield unit (HU) values
for calcifications show a wide range (usually between 100
and 400), whereas bone reaches higher HU values (700 for
trabecular bone and > 1500 HU for cortical bone [3]. On ul-
trasound, it may be difficult to distinguish between calcifica-
tions and ossification, especially when acoustic shadowing is
present. Calcifications usually demonstrate uniformly low sig-
nal intensity on all MRI sequences. Sensitivity for the detec-
tion of small calcifications may be improved by using gradient
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echo and susceptibility-weighted imaging. Phase images from
susceptibility-weighted imaging may also allow for a better
distinction between calcifications and other causes of suscep-
tibility variations [3]. Nevertheless, calcifications may still be
overlooked on MRI, particularly when small and surrounded
by other low-signal-intensity structures such as tendons, liga-
ments, and fibrosis. Therefore, it is important to correlate MRI
with other imaging modalities (including radiography, CT,
and ultrasound) when available. Mature bone shows fatty
bone marrow within trabecular spaces on both CT and MRI.
However, immature bone is not well organized and may be
more difficult to discriminate from calcifications [3].
Myositis ossificans
Myositis ossificans is a benign ossifying soft tissue mass typ-
ically occurring within skeletal muscle [4]. Of note, the term
“myositis ossificans” is a misnomer when more broadly used
to discuss heterotopic ossification, as heterotopic ossification
is neither specific to muscle nor involves prominent inflam-
mation after its early stages [5]. Nevertheless, “myositis
ossificans” is still a widely used term, both among patholo-
gists, orthopedic surgeons, and radiologists [4–7], and will be
used in this article to refer to this entity. The pathophysiology
of myositis ossificans is incompletely understood [6]. The
classic clinical history is pain, swelling, and joint stiffness
following blunt soft tissue trauma; young active males are
most commonly affected [6]. However, clinical presentation
is variable and depends on disease stage [6]. Furthermore, a
history of trauma is often inapparent [4, 6]. In fact, trauma to
the affected region is not required for the development of
myositis ossificans. For example, it is also frequently seen
around joints in patients with acquired neurologic deficit (also
known as neurogenic paraosteoarthropathy). Myositis
ossificans progresses through several stages: an early
(< 4 weeks), intermediate (4–8 weeks), and mature stage
(> 8 weeks) (Fig. 2) [6]. In the early stage, calcifications are
usually not apparent. In the intermediate stage, amorphous
calcifications appear. These calcifications produce a densely
Fig. 1 Ossification versus
calcification. a, b Mature bone
shows an outer cortex and inner
trabecular pattern. c, d
Calcifications normally appear as
mineralized densities
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calcified peripheral rim with a lucent center, typically by the
end of the intermediate stage. The mature stage is character-
ized by a peripheral rim of calcification resembling cortical
bone (Fig. 3). Mature lesions may show diffuse ossification,
typically run in parallel with the long axis of the muscle, and
often have a radiolucent cleft that separates it from adjacent
bone [6]. Nevertheless, it is important to note that ossification
adherent to bone does not exclude myositis ossificans.
Notably, the rapidity of the appearance and maturation of the
calcification in myositis ossificans is highly dependent on the
patient’s age, similar to callus formation. This is because myo-
sitis ossificans is basically represents richly vascularized gran-
ulation tissue differentiating to bone. Just as callus forms and
matures more rapidly in younger patients, the same is true of
myositis ossificans. The time frames listed for the various
stages are not necessarily accurate because of age dependence.
This typical evolution at radiography and CT is diagnostic for
myositis ossificans. Myositis ossificans has a varying appear-
ance at MRI, depending on disease stage [4, 6]. In the early
and intermediate stages, lesions may be poorly defined and
show enhancement, hemorrhage, fluid-fluid levels, and sur-
rounding soft tissue edema (Fig. 4) [4, 6, 7]. In the mature
stage, myositis ossificans tends to be well defined with inter-
nal trabecular bone with mature fat (corresponding to marrow
in heterotopic bone) and resolution of surrounding edema [4,
6, 7]. Similar to enhancement at MRI, myositis ossificans can
show intense tracer uptake at bone scintigraphy and FDG PET
in early and intermediate stages, which progressively reduces
as maturation occurs [6, 8]. Diagnosis of myositis ossificans
can be challenging in early and intermediate stages, especially
when there is no clear history of trauma. Parosteal osteosar-
coma, soft tissue sarcoma associated with calcifications (such
Fig. 2 A 24-year-old man with
myositis ossificans, early to inter-
mediate stage (a, b) and late stage
(c, d). a, b Initial radiography
shows amorphous calcifications
in the soft tissue at the posterolat-
eral side of the distal femur. c, d
Follow-up radiography after
1.5 years shows ossification
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as synovial sarcoma), and soft tissue abscess are in the differ-
ential diagnosis. Close imaging surveillance or biopsy are
warranted in indeterminate cases. However, in the early stage
it may also be difficult to pathologically distinguish myositis
ossificans from extraskeletal osteosarcoma [6].When in doubt
about the diagnosis of myositis ossificans, patients should be
referred to a tertiary care center with expertise in sarcomas.
Tophaceous gout
Gout is a crystal arthropathy resulting frommonosodium urate
crystal deposition in and around the joints. Monosodium urate
crystals can precipitate with calcium when extraarticular and
not in solution (intraarticular). Transplant recipients, females,
and elderly people in particular can develop gouty tophi as an
initial manifestation of their disease [9]. Tophaceous gout can
affect almost any part of the body and mimic a malignant soft
tissue tumor [9, 10]. At radiography and CT, hyperdense
(Fig. 5) soft tissue swelling can be seen and presence of dense
calcifications is a late finding [11]. At ultrasound, tophi are
generally hyperechoic, heterogeneous, poorly defined, multi-
ple grouped, and surrounded by an anechoic halo [12]. At
MRI, they generally show intermediate T1 signal intensity,
variable T2 signal intensity, and enhancement (Fig. 5) [13].
These MRI features do not help to discriminate tophaceous
gout from a malignancy (e.g., synovial sarcoma), especially
Fig. 3 A 54-year-old woman with myositis ossificans, mature stage.
Radiography shows a well-defined lesion with peripheral ossification in
the soft tissue at the medial side of the right femoral diaphysis (arrow),
representing mature stage myositis ossificans
Fig. 4 A 6-year-old girl with
myositis ossificans, intermediate
stage. a Radiography shows an
ill-defined calcified lesion cranial
to the right greater trochanter. b
Coronal turbo inversion recovery
magnitude image shows exten-
sive soft tissue edema surround-
ing the lesion in the right gluteus
maximus muscle. c, d Coronal
pre- (c) and postgadolinium (d)
T1-weighted images with fat
suppression show enhancement
of the lesion in the right gluteus
maximus muscle and surrounding
soft tissue. Because of persisting
pain, the lesion was finally
resected and pathologically prov-
en to be myositis ossificans
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when the clinical and biochemical presentation and location
are atypical. However, multifocality is often a clue that a ma-
lignant neoplasm is unlikely. Biopsy may be needed to defin-
itively establish the diagnosis. Alternatively, dual-energy CT
may be used, as it can accurately identify monosodium urate
crystals [14, 15]. It is important to mention that biopsy of gout
can be very confusing and difficult for pathologists for diag-
nosis if the material is placed in typical formalin as the diag-
nostic needle-shaped crystals dissolve. An alcohol solution
should be used if gout is a potential diagnosis at biopsy, or
the biopsy sample should be sent unfixed or “fresh”.
Benign vascular lesions
Venous malformations are the most common peripheral vas-
cular malformation. They can occur anywhere, but are usually
located in the head and neck (40% of cases), trunk (20%), and
extremities (40%) [16]. Venous malformations increase pro-
portionally with body growthwithout regression [16]. Patients
usually become symptomatic in late childhood or early adult-
hood [16]. Venous malformations may permeate across tissue
planes and invade multiple adjacent tissues (fat, muscle, ten-
don, bone) [16]. When they are superficially located, venous
malformations appear as faint blue, soft, easily compressible,
and nonpulsatile masses [16]. They characteristically enlarge
with the Valsalva maneuver and in dependent positions [16].
Symptoms may include pain, impaired mobility, and skeletal
deformity [16]. Phleboliths are present in approximately 50%
of venous malformations (Fig. 6) [17] and are the result of
stagnant blood flow due to thrombosis [18]. CT is more sen-
sitive than radiography in detecting phleboliths [17]. Unlike
slow-f low vascular malformat ions (both venous
malformations and hemangioma) that tend to produce
phleboliths, high-flow vascular lesions tend to produce more
“tram-track” calcifications seen in arteries. Vascular
malformations have a variable ultrasound appearance: they
can be ill defined or well defined, typically have a heteroge-
neous echogenicity with multiple cystic spaces, and they may
or may not show vascularity on color Doppler [19].
Nevertheless, these lesions frequently exhibit a typical
“sponge”-like appearance on ultrasound and can be com-
pressed with mechanical pressure. The standard for imaging
evaluation is MRI (Fig. 6). Venous malformations appear as a
septated lobulated mass without mass effect and usually dem-
onstrate (besides phleboliths) fluid-fluid levels, low T1 signal
intensity, high T2 signal intensity, no-flow voids, and slow
gradual enhancement on delayed images [16]. Fat is common-
ly interspersed between stromal elements and fluid pockets,
and there are commonly tubular structures (serpentine mor-
phology). Perilesional edema may be present [16]. Given that
imaging is often diagnostic, biopsy can generally be avoided
[17]. Notably, biopsy attempts may yield insufficient solid
tissue for pathologic analysis and can lead to bleeding com-
plications [17].
Calcium hydroxyapatite deposition disease
Calcific tendinopathy is a common, usually self-limiting dis-
order due to deposition of calcium hydroxyapatite within ten-
dons, usually of the rotator cuff. The adjacent bone may oc-
casionally be involved [20–23], whichmost commonly occurs
in the femur and humerus (typically the humeral and femoral
tuberosities) [20]. Other soft tissue structures like bursae and
joint capsule may also be involved. Pain is frequent, although
patients may be asymptomatic [20]. Calcific tendinopathy
with osseous involvement has an aggressive imaging
Fig. 5 A 60-year-old woman with tophaceous gout. a, b Radiography (a)
and coronal CT (b) show a soft tissue lesion with calcifications near the
lateral epicondyle of the distal humerus. c Coronal postgadolinium T1-
weighted images with fat suppression demonstrates peripheral enhance-
ment of the lesion. Biopsy was performed, demonstrating monosodium
urate crystals, consistent with gout
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appearance. Marked edema and enhancement in the bone
around the calcifications (which is the main finding), cortical
destruction, and periosteal reaction may mimic malignancy
(e.g., soft tissue sarcoma, periosteal sarcoma, or metastatic
disease) or infection (Fig. 7) [20–23]. Correlating MRI with
radiographic findings or CT is important because tendon cal-
cifications might not be readily appreciated onMRI alone [20,
22]. The characteristic location of calcifications in a tendon
and absence of an associated soft tissue mass should provide
the necessary clues to the correct diagnosis and avoidance of
biopsy [20–23]. The other feature that is helpful to distinguish
calcific tendinopathy from malignancy is the prominent asso-
ciated bone marrow edema on MRI, which is not a typical
finding with deep-seated sarcomas. Importantly, calcium hy-
droxyapatite deposition disease does not have to occur within
the tendon, and it occurs in many places besides the rotator
cuff. It is frequently seen around the hip and is particularly
difficult to distinguish from tumor/infection/trauma when it
Fig. 7 A 53-year-old woman with calcific tendinopathy of the
infraspinatus tendon with osseous involvement. a Radiography shows
soft tissue calcifications posteriorly to the humeral head. b Coronal
oblique turbo inversion recovery magnitude image shows intra-osseous
extension of calcification (arrowhead) and surrounding bone marrow
edema. c Axial T1-weighted image with fat suppression after intra-
articular injection of gadolinium shows calcifications which are located
in the infraspinatus tendon and in the humeral head (arrowheads). There
is no associated soft tissue mass
Fig. 6 A 38-year-old man with a venous malformation. a Radiography
shows suprapatellar phleboliths. b Sagittal T1-weighted image shows a
lobulated mass with low signal intensity. cAxial proton-density weighted
image with fat suppression shows the mass in the vastus medialis muscle
to have high signal intensity and internal signal voids (arrowheads),
representing phleboliths. d, e Axial pre- (d) and postgadolinium (e) T1-
weighted images with fat suppression show enhancement of the mass. In
this figure, fat overgrowth and serpentine morphology are also keys to the
correct diagnosis of venous malformation
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occurs in the cervical spine. Therefore, this diagnosis should
always be considered in the setting of acute onset pain and
periarticular calcifications.
Periosteal chondroma
Periosteal chondroma, also known as juxtacortical
chondroma, is a rare benign chondral tumor arising from the
periosteum [24, 25]. Preferred locations are metaphyses of
long tubular bones, hands and feet, and the osseous insertions
of tendons and ligaments [24]. It predominantly occurs in men
who are in their 2nd to 4th decades [24, 25]. Focal swelling
and pain are the most common clinical symptoms [24, 25].
The typical radiographic appearance of periosteal chondroma
is a calcified chondroid matrix with scalloping and slightly
overhanging edges of the cortex of adjacent bone (Figs. 8
and 9) [26]. At MRI, the lesion typically shows a lobulated
configuration and no edema in adjacent bone and soft tissue
(Figs. 8 and 9). Signal intensity of cartilaginous tissue is T1
hypo- or isointense relative to muscle and T2 hyperintense
relative to fat. The calcified chondroid matrix shows signal
loss (Figs. 8 and 9). Contrast enhancement is typically accord-
ing to a “septal pattern”, meaning peripheral enhancement
with linear or curvilinear internal enhancement (Figs. 8 and
9) [24]. Imaging features of periosteal chondroma and perios-
teal chondrosarcoma also show variable overlap [25, 27]. Size
is the most reliable indicator: when lesion size exceeds 3 cm,
chondrosarcoma is more likely [25]. In addition, periosteal
chondroma tends to lack associated medullary bone or soft
tissue edema. Nevertheless, chondrosarcomas do not
necessarily show edema. Treatment of both lesions is surgical,
with a local excision for periosteal chondroma and a wide
excision for periosteal chondrosarcoma [25]. Periosteal
chondroma may be easier to distinguish from periosteal/
parosteal osteosarcoma because the latter shows an osseous
rather than a chondroid matrix.
Primary synovial chondromatosis
Primary synovial chondromatosis is an uncommon benign
neoplastic process with development of intrasynovial cartilage
nodules in a joint, tendon sheath, or bursa [28]. These nodules
enlarge and detach from the synovium. The disorder most
commonly occurs in male adults. The knee and hip are predi-
lection sites [28]. Clinical symptoms typically are pain, swell-
ing, and restriction of range of motion of the affected joint
[28]. Radiographs reveal multiple intraarticular calcifications
in the majority of cases, which frequently show a pathogno-
monic appearance of being innumerable and similarly shaped
[28]. In addition, a typical chondroid ring-and-arc mineraliza-
tion pattern may be present (Fig. 10) [28]. However, because
the lesions are small, ring-and-arc calcifications are not fre-
quently visible in primary synovial chondromatosis.
Fragments may ossify and display a peripheral rim of cortex
and inner trabecular bone (Fig. 10) [28]. A target appearance
may also be seen, consisting of a single peripheral rim and
central dot of calcification [28]. Mechanical pressure of the
intra-articular fragments can cause extrinsic bone erosions and
secondary osteoarthritis can occur [28]. CT is the optimal
imaging modality to evaluate calcifications and detect bony
Fig. 8 A 48-year-old man with
periosteal chondroma. a
Radiography shows soft tissue
lesion with a calcified chondroid
matrix lateral to the proximal
phalanx of the first digit. b–d
Axial T1-weighted image (b),
coronal proton-density-weighted
image with fat suppression (c),
and coronal postgadolinium T1-
weighted image with fat suppres-
sion (d) show pressure erosion of
neighbouring bone without asso-
ciated medullary bone. The lesion
also displaces the flexor hallucis
longus tendon. There is no soft
tissue edema. The lesion shows a
septal enhancement pattern (d)
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erosions [28]. MRI signal characteristics are variable, depend-
ing on the degree of calcifications [28]. Enhancement is typ-
ical of hyaline cartilage neoplasms, with a characteristic pe-
ripheral and septal pattern [28]. Although uncommon (in ap-
proximately 5% of cases), primary chondromatosis can under-
go malignant transformation to synovial chondrosarcoma [28,
29]. It can be very difficult to distinguish these entities, both
pathologically and radiologically [28, 29]. However, multiple
recurrences and development of marrow invasion should be
considered alarming features [28].
Hoffa’s disease
Hoffa disease is a syndrome of impingement and probably
caused by acute or repetitive trauma leading to hemorrhage
in Hoffa’s fat pad [30, 31]. The inflamed fat pad then becomes
hypertrophied, which predisposes it to crushing between the
femur and tibia and to a vicious cycle of hemorrhage, inflam-
mation, and further hypertrophy [30, 31]. Hoffa’s disease most
commonly occurs in young women, who typically present
with anterior knee pain [30]. Practicing of jumping sports
and ligamentous laxity causing knee hyperextension are
predisposing factors [29]. Acute edema and hemorrhage with-
in the swollen fat pad characteristically manifest as areas of
increased T2 signal intensity [30, 31]. Bowing of the patellar
tendon from mass effect is seen frequently and a small joint
effusion may be present (Fig. 11) [30, 31]. In the subacute and
chronic phases, fibrin and hemosiderin have low T1 and T2
signal intensity (Fig. 11) [30, 31]. Fibrous tissue may trans-
form into fibrocartilaginous tissue and eventually ossify [30,
31], which can be seen at radiography (Fig. 11). The exact
frequency of ossification in Hoffa’s disease is currently un-
known. Synovial sarcoma can arise in Hoffa’s fat pad [32] and
could be included in the differential diagnosis, along with
venous malformation. However, ossification is an unusual
phenomenon in both synovial sarcoma and venous malforma-
tion. Therefore, it is very important to differentiate calcifica-
tions (which can be present in synovial sarcoma and venous
malformation) from ossification at imaging.
Tumoral calcinosis
Tumoral calcinosis is a rare hereditary disease caused by met-
abolic dysfunction of phosphate regulation associated with
Fig. 9 A 16-year-old boy with
periosteal chondroma. a
Radiography shows a calcified
chondroid matrix laterally to the
proximal radial diaphysis. b, c
Axial T1-weighted (a) and T2-
weighted (b) images show that
the lesion is located directly adja-
cent to the radius. Signal intensity
of the lesion is nearly isointense to
muscle on T1-weighted images
and hyperintense to T2-weighted
images, with areas of signal loss
which represent the calcified
chondroid matrix. d Coronal
postgadolinium T1-weighted im-
age with fat suppression shows a
septal enhancement pattern
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massive periarticular calcinosis [33]. Black patients are pre-
dominantly affected [33]. Calcified masses most commonly
occur around the hip, elbow, shoulder, foot, and wrist, and are
not painful unless impinging on a local nerve [33]. Chalky
white matter may extrude from late-stage skin ulcers [33].
The radiographic appearance of tumoral calcinosis is a lobu-
lated calcific soft tissue mass (Fig. 12), which is typically
cystic, has a bursal distribution, and usually affects extensor
surfaces [33]. CT is the modality of choice to delineate the
calcific mass (Fig. 12). Multiple fluid-calcium levels may be
seen and although there is usually no osseous involvement
[33], it is definitely possible for tumoral calcinosis to erode
adjacent bone. On MRI, tumoral calcinosis has been reported
to appear as a heterogeneous lesion with low T1 signal inten-
sity and high T2 signal intensity [33]. However, in our expe-
rience, lesions usually show low T2 signal intensity as would
be expected for calcification (Fig. 12). Enhancement may be
present in the walls of the cystic parts of the lesion because of
hypervascularity [34]. Positron emission tomography is not
useful to differentiate tumoral calcinosis from malignancy be-
cause tumoral calcinosis can demonstrate avid FDG uptake
[35–37]. Differential diagnostic considerations include,
amongst others, calcinosis associated with chronic renal fail-
ure and soft tissue sarcoma [32]. Careful review of clinical
history, laboratory test results, location, and imaging appear-
ance helps to differentiate tumoral calcinosis from these enti-
ties. Tumoral calcinosis does not have noncalcified compo-
nents as expected for synovial sarcoma, extraskeletal osteo-
sarcoma, or chondrosarcoma. Another helpful feature in dis-
tinction frommalignant neoplasms is the multifocality in most
cases of tumoral calcinosis. There are several mimics of tumor
calcinosis that share the same radiologic features, including
similar distribution, size, and morphology. Mimics of tumor
calcinosis can broadly be divided into metabolic calcification
(associated with abnormal calcium and/or phosphate levels)
and dystrophic calcification (resulting from an underlying in-
flammatory process, including connective tissue diseases and
(atypical) infections), as described in detail elsewhere [33].
The most frequent cause of a periarticular calcified mass is
chronic renal failure [33]. Of interest, the specific cause un-
derlying the development of massive periarticular calcifica-
tion in chronic renal failure remains unknown [33]. Notably,
tumoral calcinosis and calcinosis associated with chronic renal
failure have similar radiologic and pathologic appearance but
Fig. 10 A 19-year-old man with
primary synovial chondromatosis
of the knee. a Radiography shows
a soft tissue lesion with ring- and
arc-like calcifications posteriorly
to the knee. b Sagittal T1-
weighted image shows an addi-
tional ossified fragment in the
suprapatellar recess (arrowhead).
c Axial T2*-weighted image
shows the calcified part of the le-
sion as an area of signal loss
(arrowhead). d Sagittal
postgadolinium T1-weighted im-
age with fat suppression shows
diffusely thickened and enhanc-
ing synovium. The lesion poste-
riorly to the knee (arrowhead)
shows no internal enhancement
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treatment is different: surgical excision may be effective in
some cases of tumoral calcinosis [33, 38], whereas a more
conservative approach is indicated in calcinosis associated
with chronic renal failure [38]. Therefore, whenever the diag-
nosis of tumoral calcinosis is suggested by imaging, calcium-
phosphate metabolic parameters and renal function should be
checked [38].
Lipoma with metaplasia
Lipoma with metaplastic bone (also referred to as
osteolipoma) is a rare variant of lipoma in which both mature
adipose tissue and mature lamellar bone are present [1, 39,
40]. Patients usually present with a soft tissue mass, which
may be painful [39–44]. Lipoma with metaplastic bone may
arise in several anatomic locations, including the soft tissues
in the neck [43], the oral cavity [42], and extremities
[39–41]. Notably, it is considered a different entity than
parosteal lipoma, which is also a lipoma variant but contig-
uous with periosteal bone and commonly associated with
reactive changes in the underlying cortex [44, 45].
Prognosis of lipoma with metaplastic bone is similar to sim-
ple lipoma and no recurrences after surgical excision have
been reported in the literature, to our knowledge [39, 42–44].
On imaging, lipoma with metaplastic bone appears as a well-
defined tumor, which respects anatomical boundaries.
Besides fat and bone, calcifications can also be present.
Radiography can show the calcifications and trabecular bone.
When they are largely ossified, lipomas with metaplastic
bone may be difficult to appreciate on ultrasound. CT and
MRI are the imaging modalities of choice to characterize the
tumor and to exactly demonstrate tumor size, location, and
extent (Fig. 13). Intratumoral non-fatty components such as
bone and cartilage (note that lipomas can also exhibit
chondroid matrix calcification and not just ossification)
may confound the imaging diagnosis and mimic chondroma
or extraskeletal osteochondroma, another rare, benign soft
tissue tumor [46]. Lipomas with metaplastic bone may show
intense and heterogeneous enhancement (Fig. 13) [39, 41].
In these cases, the possibility of a soft tissue sarcoma (par-
ticularly liposarcoma with calcifications and ossification
[47]) should be included in the differential diagnosis and
pathological evaluation is warranted. Similar to the radiolo-
gist, the pathologist may also be confused in making the
correct diagnosis because of the presence of non-fatty com-
ponents within the tumor. Close correlation between imaging
and pathological findings aids in correctly diagnosing lipoma
with metaplastic bone. Cytogenetic analysis may be used in
larger tumors with worrisome features [39].
Fig. 11 A 68-year-old man with
Hoffa’s disease. a Radiography
shows multiple ossified fragments
(arrow) in Hoffa’s fat pad. b
Sagittal T1-weighted image
shows the largest ossified frag-
ment in Hoffa’s fat pad, with sur-
rounding low signal intensity. c, d
Sagittal (a) and coronal (b)
proton-density-weighted images
with fat suppression show high
signal intensity in Hoffa’s fat pad
with areas of low signal intensity,
corresponding to fibrin and
hemosiderin
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Calcifying aponeurotic fibroma
Calcifying aponeurotic fibroma is a rare benign but locally
aggressive fibroblastic tumor that most commonly affects
the deep volar fascia, tendons, and aponeuroses of the hands,
followed by the feet [48]. Less frequently involved sites in-
clude the neck, thigh, forearm, popliteal fossa, and lumbosa-
cral region [48]. It typically occurs in children and adoles-
cents, and males are more commonly affected than females
[48]. It is one of the few fibrous lesions that can calcify [48].
Therefore, it should be included in the differential diagnosis
when a calcifying mass is seen in young children around the
hand/wrist. The typical clinical manifestation is that of a slow-
growing, poorly circumscribed soft tissue mass that does not
limit joint motion [48]. Radiography and ultrasound may
show a nonspecific soft tissue mass with a variable extent of
fine, stippled calcifications (Fig. 14) [48]. CT is optimal for
depicting the calcified areas of the lesion, with other regions
demonstrating nonspecific soft tissue attenuation [48]. At
MRI, calcifying aponeurotic fibroma appears as a round to
oval superficial subcutaneous soft tissue mass with an ill-
defined appearance, and a tendency to infiltrate into or adhere
to the surrounding tissues [48–50]. Masses usually show low
to isointense T1 signal intensity, overall heterogeneously high
T2 signal intensity (Fig. 14), and heterogeneous intense en-
hancement [40, 50]. There are no reliable imaging features
which discriminate calcifying aponeurotic fibroma from soft
tissue sarcoma (particularly synovial sarcoma and undifferen-
tiated pleomorphic sarcoma) [48, 50]. Therefore, biopsy and
pathological analysis are warranted.
Calcific myonecrosis
Calcific myonecrosis is a rare posttraumatic entity, in which a
muscle is replaced by a fusiform mass with central liquefac-
tion and peripheral calcifications [51, 52]. It is assumed that
calcific myonecrosis results from muscle ischemia and cystic
degeneration, which is supported by the strong association
with a remote history of compartment syndrome and/or
Fig. 12 A 62-year-old woman
with tumoral calcinosis. a
Radiography shows a well-
circumscribed calcified soft tissue
mass (arrow) near the right
shoulder. b Axial CT that the cal-
cified mass is located within the
lateral part of the pectoralis major
muscle and extends subcutane-
ously. cAxial T2-weighted image
shows that the lesion has low
signal intensity. d Axial T1-
weighted image with fat suppres-
sion demonstrates low signal in-
tensity of the mass and a thin rim
of peripheral enhancement
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vascular injury after fracture [51, 52]. Patients often present
many (reportedly 10 to 64) years after the inflicting traumatic
event [51, 52]. Characteristic symptoms are a slowly enlarg-
ing, usually painful soft tissue mass in the anterior compart-
ment of the lower leg [51, 52]. Enlargement of the mass is
caused by repeated intralesional hemorrhage [51]. Although
less common, calcific myonecrosis can also occur in other
compartments of the lower leg, the thigh, and forearm [51].
The long time interval after the inflicting trauma and presence
of alarming clinical symptoms may lead to suspicion of ma-
lignancy or infection. Calcific myonecrosis has a typical im-
aging appearance. Radiography shows a mass with
peripherally oriented plaque-like amorphous calcifications
(Fig. 15) [51, 52]. These calcifications are present within the
entire involved muscle and usually linear in orientation and
sheet-like [51, 52]. Smooth bony erosions may be present
(presumably due to a chronic pressure effect), with minimal
periosteal reaction [51, 52]. CT and MRI readily show the
compartmental involvement of a well-defined mass with a
liquid-appearing center and peripheral calcifications
(Fig. 15) [51, 52]. Fluid-calcium levels may be seen
representing communication between the necrotic muscle
and the tendon sheath [52]. Calcific myonecrosis typically
shows a homogeneous intermediate T1 signal intensity and a
Fig. 13 A 68-year-old man with
lipoma with metaplastic bone. a
Axial CT shows a well-defined
mass (arrow) with ossifications
intermixed with fatty tissue in the
left ischiofemoral space. b Axial
T1-weighted image shows the
fatty tissue within the mass. c, d
Axial pre- (c) and postgadolinium
(d) T1-weighted images with fat
suppression show enhancing
areas in the anterior part of the
mass (arrowheads). Pathological
analysis after resection confirmed
lipoma with metaplastic bone
Fig. 14 A 13-year-old boy with calcifying aponeurotic fibroma. a
Ultrasound image in the sagittal plane shows a well-defined hypoechoic
mass (arrow) with multiple fine hyperechoic reflections (representing fine
calcifications) at the plantar side of the right forefoot. b Sagittal T1-
weighted image demonstrates the mass (near the skin marker) to be
isointense to muscle. c Coronal turbo inversion recovery magnitude im-
age demonstrates the mass (arrow) to be hyperintense. Pathological anal-
ysis after resection confirmed aponeurotic fibroma with presence of mul-
tiple fine calcifications
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heterogeneously high T2 signal intensity throughout the cen-
tral liquid-appearing region, and no enhancement [52].
Ancient schwannoma
Ancient schwannomas are long-standing, slow-growing
schwannomas that show advanced degeneration. They are
usually located deep in the head and neck, chest,
retroperitoneum, pelvis, and extremities of elderly patients
[53]. Because of their deep location, they can grow con-
siderably large before becoming symptomatic. Ancient
schwannomas typically show cystic necrosis and calcifica-
tions [53–55], findings that can be identified on imaging
(Fig. 16). Calcification is the usual degenerative change,
but ossification may also occur although rarely [53].
Because ancient schwannoma can contain cystic necrotic
areas and hemorrhage, they may mimic sarcoma or malig-
nant peripheral nerve sheath tumor [53–55]. It has been
suggested that the presence of an enhancing fibrous cap-
sule and the “split fat sign” (a rim of fat surrounding the
tumor) at MRI are helpful to differentiate ancient
schwannoma from malignant tumors [55]. However, the
“split fat sign” is only seen in ancient schwannomas in
the extremities and it does not exclude malignant periph-
eral nerve sheath tumor. In addition, the “split fat sign” is
non-specific and can be seen in other entities besides neu-
rogenic tumors. Furthermore, peripheral enhancement may
also be seen in malignant tumors. Therefore, biopsy usual-
ly is indicated to exclude malignancy.
Castleman disease
Castleman disease is an uncommon benign nonclonal
lymphoproliferative disorder, which may present as a
localized or multicentric form. The localized form typi-
cally occurs earlier in life (3rd and 4th decades) and
may be asymptomatic. The multicentric form occurs lat-
er in life (5th and 6th decades) and systemic inflamma-
tory symptoms are common [56, 57]. Although
Castleman disease primarily involves lymphatic tissues,
any extralymphatic site may be involved [57, 58].
Therefore, it can present as a worrisome soft tissue le-
sion. The typical imaging appearance is that of a soli-
tary enlarged lymph node or localized nodular lesions
which demonstrate homogeneous and intense enhance-
ment, both at CT and MRI [57–59]. Lesions tend to
Fig. 15 A 72-year-old man with calcific myonecrosis of the anterior
compartment of the right leg. a Radiography shows a soft tissue mass
with extensive calcifications. b, cAxial (a) and coronal (b) proton-density
weighed images shows the mass to be located within the anterior com-
partment of the right lower leg, with a liquid-appearing center. d Axial CT
shows the typical peripheral calcifications
Fig. 16. A 69-year-old man with ancient schwannoma in the presacral
space. Axial CT shows a well-defined mass with hypodense center, en-
hancing capsule, and peripheral calcifications (arrowheads) in the
presacral space. Pathological analysis after biopsy confirmed ancient cys-
tic schwannoma. Themass remained unchanged after 10 years’ follow-up
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Fig. 17 A 22-year-old womanwith Castleman disease. aAxial CTshows
a well-defined subcutaneous soft tissue mass with central calcification at
the left thoracic region. b, c Axial pre- (b) and postgadolinium (c) T1-
weighted images with fat suppression show homogeneous enhancement
of the mass (except for the central calcification). The mass was biopsied
and pathologically proven to be Castleman disease





Typical clinical features Specific imaging features Main differential diagnostic
consideration(s)
Myositis ossificans Pain, swelling, and joint stiffness following
blunt soft tissue trauma
Calcified peripheral rim with a lucent center
(end of intermediate stage) and pronounced
peripheral bone formation (mature stage)
Soft tissue osteosarcoma
Tophaceous gout Frequency increases with age, male
predominance, elevated serum urate levels
Multifocality and presence of monosodium
urate crystals, which can accurately be
identified by dual-energy CT
Soft tissue sarcoma (synovial sarcoma)
Soft tissue venous
malformation
Superficial lesions appear as faint blue, soft,
easily compressible, and nonpulsatile
masses, which enlarge with Valsalva
maneuver
Presence of phleboliths, lack of flow voids, and
slow gradual enhancement (of note, high
flow vascular lesions tend to produce more
“tram-track” calcifications seen in arteries)
Other soft tissue vascular






Pain and limitation of range of motion around
the affected area
Location of calcifications in a tendon, absence
of an associated soft tissue mass, and
prominent associated bone marrow edema
Malignancy (e.g., soft tissue sarcoma,




Often asymptomatic, but may present as
palpable and painful masses with mechanical
symptoms
Calcified chondroid matrix with scalloping and
overhanging edges of cortex of adjacent bone






Knee and hip are predilection sites Innumerable and similarly shaped intraarticular
calcifications, chondroid ring-and-arc pattern
of mineralization
Malignant transformation to synovial
chondrosarcoma
Hoffa’s disease In young women and persons practicing
jumping sports
Low T1 and T2 signal intensity areas
representing fibrin and hemosiderin
(subacute and chronic phases), and presence
of ossified fragments (chronic phase)
Synovial sarcoma, venous
malformation
Tumoral calcinosis Painless mass(es) around the hip, elbow,
shoulder, foot, or wrist
Lobulated calcific and cystic soft tissue mass,
multifocality








Slow-growing mass that does not limit joint
motion in children and adolescents (males
more commonly than females)
Most commonly affects the deep volar fascia,
tendons, and aponeuroses of the hands,
followed by the feet, and may calcify





Slowly enlarging, usually painful mass in the
anterior lower leg compartment, and remote
history of compartment syndrome and/or
vascular injury after fracture
Compartmental involvement of a well-defined
mass with liquid-appearing center and pe-
ripheral calcifications
Soft tissue sarcoma, infection
Ancient
schwannoma
In elderly patients, located deep in the head and
neck, chest, retroperitoneum, or pelvis
Cystic necrosis and calcifications Soft tissue sarcoma, malignant
peripheral nerve sheath tumor
Castleman disease Either asymptomatic or local symptoms due to
mass effect in unicentric disease, whereas
B-symptoms, generalized lymphadenopathy,
hepatomegaly, and splenomegaly can be seen
in multicentric disease
Internal calcification (in 5–10% of lesions) and
homogeneous and intense enhancement
Lymphoma, soft tissue sarcoma
*Tumoral calcinosis and calcinosis associated with chronic renal failure have similar radiologic and histopathologic appearance. Therefore, whenever the
diagnosis of tumoral calcinosis is suggested by imaging, calcium-phosphate metabolic parameters and renal function should be checked
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be heterogeneously T1 iso- to hyperintense relative to
muscle and T2 hyperintense [57–59]. Importantly, ap-
proximately 5–10% of lesions have internal calcifica-
tions at CT (Fig. 17) [57, 58], a feature which helps
to differentiate them from untreated lymphoma [59].
Biopsy is needed to confirm the diagnosis and to per-
form subtype classification [56].
Summary
The typical clinical features, specific imaging features,
and main differential diagnostic considerations of calci-
fied or ossified benign soft tissue lesions that may sim-
ulate malignancy are summarized in Table 1. The diag-
nosis of a benign vascular lesion, calcific tendinopathy
with osseous involvement, Hoffa’s disease, tumoral cal-
cinosis, and calcific myonecrosis can usually be confi-
dently established by their typical clinical presentations,
locations, and imaging characteristics. Some entities,
however, can be more diagnostically challenging.
Diagnosis of myositis ossificans can be difficult in the
early and intermediate stages, and biopsy or close im-
aging surveillance are warranted in indeterminate cases.
Tophaceous gout with atypical presentation can closely
resemble malignancy such as synovial sarcoma. Biopsy
or dual-energy CT can establish the definite diagnosis.
Periosteal chondroma and periosteal chondrosarcoma
may only be distinguished on imaging by size (lesions
> 3 cm are more likely chondrosarcoma). Primary
chondromatosis may be very difficult to distinguish
f r om ma l i g n a n t t r a n s f o rma t i o n t o s y n o v i a l
chondrosarcoma, both pathologically and radiologically.
Although malignant transformation is uncommon, multi-
ple recurrences and development of marrow invasion
should be considered alarming features. Osteolipomas
may show intense and heterogeneous enhancement and
resemble soft tissue sarcoma. There are no definite im-
aging features either which reliably discriminate calcify-
ing aponeurotic fibroma and ancient schwannoma from
malignancy. In these cases, biopsy and pathological
analysis are warranted.
Conclusions
There is a wide spectrum of calcified or ossified benign soft
tissue lesions that may simulate malignancy. Knowledge of
their clinical presentations, locations, and imaging character-
istics is essential to make a correct diagnosis or to narrow the
differential diagnosis, and to recommend justified further im-
aging or tissue sampling when a certain diagnosis in terms of
benignancy or malignancy cannot be made.
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